Antidepressant and anxiolytic compounds isolated from Salvia elegans interact with serotonergic drugs

Salvia elegans belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and antidepressant effects of fractions and compounds isolated from S. elegans and its interaction with serotoninergic drugs by using behavioral tes...

Full description

Saved in:
Bibliographic Details
Published inNaunyn-Schmiedeberg's archives of pharmacology Vol. 394; no. 12; pp. 2419 - 2428
Main Authors Martínez-Hernández, Gabriela Belen, Jiménez-Ferrer, Enrique, González-Cortazar, Manases, Román-Ramos, Rubén, Tortoriello, Jaime, Vargas-Villa, Gabriela, Herrera-Ruiz, Maribel
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.12.2021
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0028-1298
1432-1912
1432-1912
DOI10.1007/s00210-021-02155-6

Cover

Abstract Salvia elegans belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and antidepressant effects of fractions and compounds isolated from S. elegans and its interaction with serotoninergic drugs by using behavioral tests in mice. Fractions from aerial parts of S. elegans were obtained by column chromatography, SeF1, SeF2, SeF3, and SeF4. Each of them was administered to 25 mg/k in ICR mice subject to forced swimming test (FST), or elevated plus maze test (EPM), or open field test (OFT). The most active fractions were chemically separated until compounds, which were analyzed as anxiolytic or antidepressant and the coadministration of these treatments with 5-HT 1A and 5-HT 2 drugs was measured in the different biological tests. All fractions were anxiolytic and antidepressant, oleanolic acid (OA) was found in SeF2, and from SeF3, a mixture of terpenes was found; a GC–MS analysis confirmed the presence of two main compounds: rosifoliol and agaraspirol (TM, mixture of terpenes). TM (doses-response curve, 0.01, 0.1, 0.5, 1.0, and 2.0 mg/kg) and OA (5 mg/kg) were also evaluated demonstrating an antidepressant and anxiolytic effect, respectively. The combination of TM (0.5 mg/kg) with 8-OH (selective 5-HT 1A receptor agonist) induced an increment of antidepressant activity, while with the antagonist WAY-100635, the effect diminished. But with DOI (5-HT 1 c/5-HT 2  receptor agonist), there was no change, and with KET (5-HT 2 receptor antagonist), the activity was increased. When OA is co-administered with 8-OH or with DOI, the anxiolytic activity of this terpene, diminished; but with the combination with antagonists, the effect of OA shows no change. TM and OA were antidepressant and anxiolytic, respectively, on mice exposed to different tests, and these are able to interact with serotoninergic drugs.
AbstractList Salvia elegans belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and antidepressant effects of fractions and compounds isolated from S. elegans and its interaction with serotoninergic drugs by using behavioral tests in mice. Fractions from aerial parts of S. elegans were obtained by column chromatography, SeF1, SeF2, SeF3, and SeF4. Each of them was administered to 25 mg/k in ICR mice subject to forced swimming test (FST), or elevated plus maze test (EPM), or open field test (OFT). The most active fractions were chemically separated until compounds, which were analyzed as anxiolytic or antidepressant and the coadministration of these treatments with 5-HT and 5-HT drugs was measured in the different biological tests. All fractions were anxiolytic and antidepressant, oleanolic acid (OA) was found in SeF2, and from SeF3, a mixture of terpenes was found; a GC-MS analysis confirmed the presence of two main compounds: rosifoliol and agaraspirol (TM, mixture of terpenes). TM (doses-response curve, 0.01, 0.1, 0.5, 1.0, and 2.0 mg/kg) and OA (5 mg/kg) were also evaluated demonstrating an antidepressant and anxiolytic effect, respectively. The combination of TM (0.5 mg/kg) with 8-OH (selective 5-HT receptor agonist) induced an increment of antidepressant activity, while with the antagonist WAY-100635, the effect diminished. But with DOI (5-HT c/5-HT  receptor agonist), there was no change, and with KET (5-HT receptor antagonist), the activity was increased. When OA is co-administered with 8-OH or with DOI, the anxiolytic activity of this terpene, diminished; but with the combination with antagonists, the effect of OA shows no change. TM and OA were antidepressant and anxiolytic, respectively, on mice exposed to different tests, and these are able to interact with serotoninergic drugs.
Salvia elegans belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and antidepressant effects of fractions and compounds isolated from S. elegans and its interaction with serotoninergic drugs by using behavioral tests in mice. Fractions from aerial parts of S. elegans were obtained by column chromatography, SeF1, SeF2, SeF3, and SeF4. Each of them was administered to 25 mg/k in ICR mice subject to forced swimming test (FST), or elevated plus maze test (EPM), or open field test (OFT). The most active fractions were chemically separated until compounds, which were analyzed as anxiolytic or antidepressant and the coadministration of these treatments with 5-HT1A and 5-HT2 drugs was measured in the different biological tests. All fractions were anxiolytic and antidepressant, oleanolic acid (OA) was found in SeF2, and from SeF3, a mixture of terpenes was found; a GC-MS analysis confirmed the presence of two main compounds: rosifoliol and agaraspirol (TM, mixture of terpenes). TM (doses-response curve, 0.01, 0.1, 0.5, 1.0, and 2.0 mg/kg) and OA (5 mg/kg) were also evaluated demonstrating an antidepressant and anxiolytic effect, respectively. The combination of TM (0.5 mg/kg) with 8-OH (selective 5-HT1A receptor agonist) induced an increment of antidepressant activity, while with the antagonist WAY-100635, the effect diminished. But with DOI (5-HT1c/5-HT2 receptor agonist), there was no change, and with KET (5-HT2 receptor antagonist), the activity was increased. When OA is co-administered with 8-OH or with DOI, the anxiolytic activity of this terpene, diminished; but with the combination with antagonists, the effect of OA shows no change. TM and OA were antidepressant and anxiolytic, respectively, on mice exposed to different tests, and these are able to interact with serotoninergic drugs.Salvia elegans belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and antidepressant effects of fractions and compounds isolated from S. elegans and its interaction with serotoninergic drugs by using behavioral tests in mice. Fractions from aerial parts of S. elegans were obtained by column chromatography, SeF1, SeF2, SeF3, and SeF4. Each of them was administered to 25 mg/k in ICR mice subject to forced swimming test (FST), or elevated plus maze test (EPM), or open field test (OFT). The most active fractions were chemically separated until compounds, which were analyzed as anxiolytic or antidepressant and the coadministration of these treatments with 5-HT1A and 5-HT2 drugs was measured in the different biological tests. All fractions were anxiolytic and antidepressant, oleanolic acid (OA) was found in SeF2, and from SeF3, a mixture of terpenes was found; a GC-MS analysis confirmed the presence of two main compounds: rosifoliol and agaraspirol (TM, mixture of terpenes). TM (doses-response curve, 0.01, 0.1, 0.5, 1.0, and 2.0 mg/kg) and OA (5 mg/kg) were also evaluated demonstrating an antidepressant and anxiolytic effect, respectively. The combination of TM (0.5 mg/kg) with 8-OH (selective 5-HT1A receptor agonist) induced an increment of antidepressant activity, while with the antagonist WAY-100635, the effect diminished. But with DOI (5-HT1c/5-HT2 receptor agonist), there was no change, and with KET (5-HT2 receptor antagonist), the activity was increased. When OA is co-administered with 8-OH or with DOI, the anxiolytic activity of this terpene, diminished; but with the combination with antagonists, the effect of OA shows no change. TM and OA were antidepressant and anxiolytic, respectively, on mice exposed to different tests, and these are able to interact with serotoninergic drugs.
Salvia elegans belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and antidepressant effects of fractions and compounds isolated from S. elegans and its interaction with serotoninergic drugs by using behavioral tests in mice. Fractions from aerial parts of S. elegans were obtained by column chromatography, SeF1, SeF2, SeF3, and SeF4. Each of them was administered to 25 mg/k in ICR mice subject to forced swimming test (FST), or elevated plus maze test (EPM), or open field test (OFT). The most active fractions were chemically separated until compounds, which were analyzed as anxiolytic or antidepressant and the coadministration of these treatments with 5-HT1A and 5-HT2 drugs was measured in the different biological tests. All fractions were anxiolytic and antidepressant, oleanolic acid (OA) was found in SeF2, and from SeF3, a mixture of terpenes was found; a GC–MS analysis confirmed the presence of two main compounds: rosifoliol and agaraspirol (TM, mixture of terpenes). TM (doses-response curve, 0.01, 0.1, 0.5, 1.0, and 2.0 mg/kg) and OA (5 mg/kg) were also evaluated demonstrating an antidepressant and anxiolytic effect, respectively. The combination of TM (0.5 mg/kg) with 8-OH (selective 5-HT1A receptor agonist) induced an increment of antidepressant activity, while with the antagonist WAY-100635, the effect diminished. But with DOI (5-HT1c/5-HT2 receptor agonist), there was no change, and with KET (5-HT2 receptor antagonist), the activity was increased. When OA is co-administered with 8-OH or with DOI, the anxiolytic activity of this terpene, diminished; but with the combination with antagonists, the effect of OA shows no change. TM and OA were antidepressant and anxiolytic, respectively, on mice exposed to different tests, and these are able to interact with serotoninergic drugs.
Salvia elegans belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and antidepressant effects of fractions and compounds isolated from S. elegans and its interaction with serotoninergic drugs by using behavioral tests in mice. Fractions from aerial parts of S. elegans were obtained by column chromatography, SeF1, SeF2, SeF3, and SeF4. Each of them was administered to 25 mg/k in ICR mice subject to forced swimming test (FST), or elevated plus maze test (EPM), or open field test (OFT). The most active fractions were chemically separated until compounds, which were analyzed as anxiolytic or antidepressant and the coadministration of these treatments with 5-HT 1A and 5-HT 2 drugs was measured in the different biological tests. All fractions were anxiolytic and antidepressant, oleanolic acid (OA) was found in SeF2, and from SeF3, a mixture of terpenes was found; a GC–MS analysis confirmed the presence of two main compounds: rosifoliol and agaraspirol (TM, mixture of terpenes). TM (doses-response curve, 0.01, 0.1, 0.5, 1.0, and 2.0 mg/kg) and OA (5 mg/kg) were also evaluated demonstrating an antidepressant and anxiolytic effect, respectively. The combination of TM (0.5 mg/kg) with 8-OH (selective 5-HT 1A receptor agonist) induced an increment of antidepressant activity, while with the antagonist WAY-100635, the effect diminished. But with DOI (5-HT 1 c/5-HT 2  receptor agonist), there was no change, and with KET (5-HT 2 receptor antagonist), the activity was increased. When OA is co-administered with 8-OH or with DOI, the anxiolytic activity of this terpene, diminished; but with the combination with antagonists, the effect of OA shows no change. TM and OA were antidepressant and anxiolytic, respectively, on mice exposed to different tests, and these are able to interact with serotoninergic drugs.
Author González-Cortazar, Manases
Martínez-Hernández, Gabriela Belen
Jiménez-Ferrer, Enrique
Vargas-Villa, Gabriela
Román-Ramos, Rubén
Tortoriello, Jaime
Herrera-Ruiz, Maribel
Author_xml – sequence: 1
  givenname: Gabriela Belen
  surname: Martínez-Hernández
  fullname: Martínez-Hernández, Gabriela Belen
  organization: Centro de Investigación Biomédica del Sur, Instituto Mexicano del Seguro Social (IMSS), Doctorado en Ciencias Biológicas Y de La Salud, División de Ciencias Biológicas Y de La Salud, Universidad Autónoma Metropolitana (UAM), Departamento de Ciencias de La Salud, División de Ciencias Biológicas Y de La Salud, Universidad Autónoma Metropolitana—Iztapalapa
– sequence: 2
  givenname: Enrique
  surname: Jiménez-Ferrer
  fullname: Jiménez-Ferrer, Enrique
  organization: Centro de Investigación Biomédica del Sur, Instituto Mexicano del Seguro Social (IMSS)
– sequence: 3
  givenname: Manases
  surname: González-Cortazar
  fullname: González-Cortazar, Manases
  organization: Centro de Investigación Biomédica del Sur, Instituto Mexicano del Seguro Social (IMSS)
– sequence: 4
  givenname: Rubén
  surname: Román-Ramos
  fullname: Román-Ramos, Rubén
  organization: Departamento de Ciencias de La Salud, División de Ciencias Biológicas Y de La Salud, Universidad Autónoma Metropolitana—Iztapalapa
– sequence: 5
  givenname: Jaime
  surname: Tortoriello
  fullname: Tortoriello, Jaime
  organization: Centro de Investigación Biomédica del Sur, Instituto Mexicano del Seguro Social (IMSS)
– sequence: 6
  givenname: Gabriela
  surname: Vargas-Villa
  fullname: Vargas-Villa, Gabriela
  organization: Centro de Investigación Biomédica del Sur, Instituto Mexicano del Seguro Social (IMSS)
– sequence: 7
  givenname: Maribel
  orcidid: 0000-0001-9056-3568
  surname: Herrera-Ruiz
  fullname: Herrera-Ruiz, Maribel
  email: cibis_herj@yahoo.com.mx, maribel.herrera@imss.gob.mx
  organization: Centro de Investigación Biomédica del Sur, Instituto Mexicano del Seguro Social (IMSS)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34568977$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1P3DAQhi20qOzS_oEeqki99JLij_gjR7SCgoTEAThbjjPZGiX21nba7r_Hy1IqceAw48M878wrvyu08MEDQp8J_k4wlmcJY0pwXdq-OK_FEVqShtGatIQu0LLMVU1oq07QKqVHjLEo2Ad0whouVCvlEsG5z66HbYSUjM-V8X2pvy6Mu-xsZcO0DbPvU-VSGE2GvhpimKo7M_52poIRNsaXoc8Qjc3VH5d_VgliyMVq3JQNfZw36SM6HsyY4NPLe4oeLi_u11f1ze2P6_X5TW2Z5LmmneXMUugoGKwYYNkNbQ8NbRRXnZCDEERIXKbSdgJaUVDgg8SGkY7Lhp2ib4e92xh-zZCynlyyMI7GQ5iTprxVWHJKVEG_vkEfwxx9cbenpCCsUbRQX16ouZug19voJhN3-t8HFoAeABtDShGGV4RgvU9JH1LSpennlLQoIvVGZF022QWfo3Hj-1J2kKZyx28g_rf9juoJLqqm-w
CitedBy_id crossref_primary_10_3390_molecules29020468
crossref_primary_10_3390_molecules29174070
crossref_primary_10_2174_0122103155271537231006074854
Cites_doi 10.1016/0163-7258(95)00004-Z
10.1111/j.1476-5381.1987.tb11329.x
10.1016/S0040-4020(01)82208-0
10.1016/j.neuropharm.2011.09.023
10.1016/j.jep.2005.12.004
10.1177/0269881114536789
10.1021/acschemneuro.7b00443
10.1007/s40263-013-0071-0
10.1016/0024-3205(95)02242-9
10.1159/000488945
10.1007/BF02244978
10.1016/j.neubiorev.2005.03.008
10.1038/266730a0
10.1016/S2215-0366(14)70220-2
10.1007/BF00207243
10.1016/S0014-2999(03)01272-X
10.1016/0014-2999(88)90019-2
10.1176/appi.books.9780890425596
10.1111/j.1476-5381.1990.tb14706.x
10.1016/j.cbi.2006.11.006
10.1016/j.neuropharm.2011.01.025
10.1016/j.jep.2006.02.003
10.1055/s-2006-957784
10.3390/molecules181113260
10.1016/j.ejphar.2004.01.031
10.2217/npy.11.12
10.1016/S0944-7113(00)80063-X
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021
2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021
– notice: 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
– notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7TK
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s00210-021-02155-6
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
ProQuest One Academic Middle East (New)

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1432-1912
EndPage 2428
ExternalDocumentID 34568977
10_1007_s00210_021_02155_6
Genre Journal Article
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
.55
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
28-
29M
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3O-
3SX
3V.
4.4
406
408
409
40D
40E
53G
5QI
5RE
5VS
67N
67Z
6NX
78A
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFEXP
AFGCZ
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
I5X
IHE
IJ-
IKXTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
L7B
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P2P
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
QOK
QOR
QOS
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK6
WK8
X7M
YLTOR
Z45
Z7U
Z7W
Z82
Z87
Z8O
Z8Q
Z8V
Z91
ZGI
ZMTXR
ZOVNA
ZXP
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TK
7XB
8FK
ABRTQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
PUEGO
ID FETCH-LOGICAL-c375t-2bc53c2eb2ea083e07bf9de424858b67f6616702ea7cb6e962ebe5f70a31b5743
IEDL.DBID 7X7
ISSN 0028-1298
1432-1912
IngestDate Fri Sep 05 04:34:00 EDT 2025
Sat Jul 26 00:03:08 EDT 2025
Wed Feb 19 02:27:12 EST 2025
Tue Jul 01 02:10:10 EDT 2025
Thu Apr 24 23:03:01 EDT 2025
Fri Feb 21 02:48:10 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Depression
5-HT drugs
Anxiety
Forced swim test
Elevated plus maze
Salvia elegans
Language English
License 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c375t-2bc53c2eb2ea083e07bf9de424858b67f6616702ea7cb6e962ebe5f70a31b5743
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-9056-3568
PMID 34568977
PQID 2597613482
PQPubID 2034514
PageCount 10
ParticipantIDs proquest_miscellaneous_2598075218
proquest_journals_2597613482
pubmed_primary_34568977
crossref_primary_10_1007_s00210_021_02155_6
crossref_citationtrail_10_1007_s00210_021_02155_6
springer_journals_10_1007_s00210_021_02155_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20211200
2021-12-00
20211201
PublicationDateYYYYMMDD 2021-12-01
PublicationDate_xml – month: 12
  year: 2021
  text: 20211200
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationTitle Naunyn-Schmiedeberg's archives of pharmacology
PublicationTitleAbbrev Naunyn-Schmiedeberg's Arch Pharmacol
PublicationTitleAlternate Naunyn Schmiedebergs Arch Pharmacol
PublicationYear 2021
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References CryanJFValentinoRJLuckiIAssessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming testNeurosci Biobehav Rev2005295475691:CAS:528:DC%2BD2MXltFWlurg%3D10.1016/j.neubiorev.2005.03.008
Villalobos-OsorioDRamírez-GonzálezIRojas-FermínLSantiago-SilvaBCarmona- ArzolaJAvedaño-MezaMComposición del aceite esencial y caracterización fisicoquímica de las hojas de Stachytarpheta mutabilis (Jacq.) VahlAv Quím201491519
CeladaPPuigMAmargós-BoschMAdellAArtigasFThe therapeutic role of 5-HT1A and 5-HT2A receptors in depressionJ Psychiatry Neurosci20042925226515309042446220
DubovskySLWhats is new about new antidepressants?Psychother Psychosom20188712913910.1159/000488945
CeladaPBortolozziAArtigasFSerotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of researchCNS Drugs2013277037161:CAS:528:DC%2BC3sXhvVSmsbbN10.1007/s40263-013-0071-0
Newman-TancrediBiased agonism at serotonin 5-HT1A receptors: preferential postsynaptic activity for improved therapy of CNS disordersNeuropsychiatry2011114916410.2217/npy.11.12
HutsonPHDourishCTCurzonGEvidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptorsEur J Pharmacol19881503613661:CAS:528:DyaL1cXkvVKisb0%3D10.1016/0014-2999(88)90019-2
CritchleyMAHandleySLEffects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptorsPsychopharmacology1987935025061:CAS:528:DyaL1cXmvVOlsw%3D%3D10.1007/BF00207243
PorsoltRDPichonMLJalifMDepression: a new model sensitive to the antidepressant treatmentNature19772667307321:CAS:528:DyaE2sXkvFGhur4%3D10.1038/266730a0
RosaADeianaMAtzeriACoronaGIncaniAMelisMPAppendinoGDessìMAEvaluation of the antioxidant and cytotoxic activity of arzanol, a prenylated alpha-pyrone-phloroglucinol etherodimer from Helichrysum italicum subsp. microphyllumChem-Biol Interact20071651171261:CAS:528:DC%2BD2sXls1eiuw%3D%3D10.1016/j.cbi.2006.11.006
HedlundPBKellyLMazurCLovenbergTSutcliffeJGBonaventureP8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodentsEur J Pharmacol20044871251321:CAS:528:DC%2BD2cXitFeiu7s%3D10.1016/j.ejphar.2004.01.031
Jastrzębska-WięsekMPartykaARychtykJŚniecikowskaJKołaczkowskiMWesołowskaAVarneyMANewman-TancrediAActivity of serotonin 5-HT1A receptor biased agonists in rat: anxiolytic and antidepressant-like propertiesACS Chem Neurosci201891040105010.1021/acschemneuro.7b00443
HeerleinAAntidepressant pharmacologic treatmentsRev Chil Neuro-Psiquiat2002403951
PrutLBelzungCThe open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a reviewEur J Pharmacol20034633331:CAS:528:DC%2BD3sXhsVanu70%3D10.1016/S0014-2999(03)01272-X
Aguilar A, Camacho J, Chino S, Jácquez P, López E (1994) Herbario de Medicina del Instituto Mexicano del Seguro Social. Información etnobotánica. México: Instituto Mexicano del Seguro Social pp. 159, 245.
DiazSMaroteauxLImplication of 5-HT(2B) receptors in the serotonin syndromeNeuropharmacol2011614955021:CAS:528:DC%2BC3MXntFWiu78%3D10.1016/j.neuropharm.2011.01.025
MottaVMaisonnetteSMoratoSCastrechiniPBrandãoMLEffects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-mazePsychopharmacology19921071351391:CAS:528:DyaK38Xit1yrsLk%3D10.1007/BF02244978
MarkouACryanJFStress, anxiety and depression: toward new treatment strategiesNeuropharmacology201262121:CAS:528:DC%2BC3MXhtlaktL3E10.1016/j.neuropharm.2011.09.023
ListerRGThe use of a plus-maze to measure anxiety in the mousePsychopharmacology1987921801851:CAS:528:DyaL2sXktlejurc%3D3110839
VarmaKRMaheshwariMLBhattacharyyaSCTerpenoids-LXII: The constitution of agarospirol, a sesquiterpenoid with a new skeletonTetrahedron1965211151381:CAS:528:DyaF2MXksVSksQ%3D%3D10.1016/S0040-4020(01)82208-0
World Health OrganizationReport: depression and other common metal disorders2017GenevaGlobal Health Estimates
DSM-V. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596
OkugawaHUedaRMatsumotoKKawanishiKKatoKEffects of sesquiterpenoids from “Oriental incenses” on acetic acid-induced writhing and D2 and 5-HT2A receptors in rat brainPhytomedicine200074174221:CAS:528:DC%2BD3cXoslWis7o%3D10.1016/S0944-7113(00)80063-X
Van HeeringenKMannJJThe Neurobiology of SuicideLancet Psychiatry20141637210.1016/S2215-0366(14)70220-2
FajemiroyeJOGaldinoPMFlorentinoIRDa RochaFFGhediniPCPolepallyPRZjawionyJKCostaEAPlurality of anxiety and depression alteration mechanism by oleanolic acidJ Psychopharmacol2014892393410.1177/0269881114536789
MoserPCTricklebankMDMiddlemissDNMirAKHibertMFFozardJRCharacterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepamBr J Pharmacol1990993433491:CAS:528:DyaK3cXhsFWlsrY%3D10.1111/j.1476-5381.1990.tb14706.x
González-CortazarMMaldonado-AbarcaAMJiménez-FerrerEMarquinaSVentura- ZapataEZamilpaATortorielloJHerrera-RuizMIsosakuranetina- 5-O- rutinoside: a new flavanone with antidepressant activity isolated from Salvia elegans VahlMolecules201318132601327010.3390/molecules181113260
OnaiviESBishop-RobinsonCDarmaniNASandres-BushEBehavioral effects of (+/)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, (DOI) in the elevated plus- maze testLife Sci199557245524661:CAS:528:DyaK2MXpsFemtr4%3D10.1016/0024-3205(95)02242-9
CristJSurprenantAEvidence that 8-hydroxy-2-(n-dipropylamino) tetralin (8-OH-DPAT) is a selective α2-adrenoceptor antagonist on guinea-pig submucous neuronsBr J Pharmacol1987923413471:CAS:528:DyaL2sXlvFSqsb8%3D10.1111/j.1476-5381.1987.tb11329.x
OkugawaHUedaRMatsumotoKKawanishiKKayoAEffect of Jnokoh- eremol and Agarospirol from Agarwood on the central nervous system in micePlanta Med1995622610.1055/s-2006-957784
MoraSMillánRLungenstrassHDíaz-VélizGMoránJAHerrera-RuizMTortorielloJThe hydroalcoholic extract of Salvia elegans induces anxiolytic- and antidepressant-like effects in ratsJ Ethnopharmacol200610676811:STN:280:DC%2BD283otl2lsA%3D%3D10.1016/j.jep.2005.12.004
HandleySL5-hydroxytryptamine pathways in anxiety and its treatmentPharmacol Ther1995661031481:CAS:528:DyaK2MXoslCnt7k%3D10.1016/0163-7258(95)00004-Z
Herrera-RuizMGarcíaYMoraSDíazGVianaSTortorielloJRamírezGAntidepressant and anxiolytic effects of hydroalcoholic extract from Salvia elegansJ Ethnopharmacol2006107535810.1016/j.jep.2006.02.003
P Celada (2155_CR3) 2013; 27
S Diaz (2155_CR7) 2011; 61
Newman-Tancredi (2155_CR23) 2011; 1
JF Cryan (2155_CR6) 2005; 29
H Okugawa (2155_CR24) 1995; 62
M Herrera-Ruiz (2155_CR15) 2006; 107
2155_CR1
V Motta (2155_CR22) 1992; 107
J Crist (2155_CR4) 1987; 92
World Health Organization (2155_CR33) 2017
M González-Cortazar (2155_CR11) 2013; 18
2155_CR8
PH Hutson (2155_CR16) 1988; 150
A Rosa (2155_CR29) 2007; 165
A Markou (2155_CR19) 2012; 62
SL Dubovsky (2155_CR9) 2018; 87
SL Handley (2155_CR12) 1995; 66
MA Critchley (2155_CR5) 1987; 93
RD Porsolt (2155_CR27) 1977; 266
M Jastrzębska-Więsek (2155_CR17) 2018; 9
JO Fajemiroye (2155_CR10) 2014; 8
L Prut (2155_CR28) 2003; 463
ES Onaivi (2155_CR26) 1995; 57
PB Hedlund (2155_CR13) 2004; 487
P Celada (2155_CR2) 2004; 29
A Heerlein (2155_CR14) 2002; 40
PC Moser (2155_CR21) 1990; 99
KR Varma (2155_CR31) 1965; 21
K Van Heeringen (2155_CR30) 2014; 1
RG Lister (2155_CR18) 1987; 92
H Okugawa (2155_CR25) 2000; 7
S Mora (2155_CR20) 2006; 106
D Villalobos-Osorio (2155_CR32) 2014; 9
References_xml – reference: DubovskySLWhats is new about new antidepressants?Psychother Psychosom20188712913910.1159/000488945
– reference: HutsonPHDourishCTCurzonGEvidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptorsEur J Pharmacol19881503613661:CAS:528:DyaL1cXkvVKisb0%3D10.1016/0014-2999(88)90019-2
– reference: PorsoltRDPichonMLJalifMDepression: a new model sensitive to the antidepressant treatmentNature19772667307321:CAS:528:DyaE2sXkvFGhur4%3D10.1038/266730a0
– reference: Newman-TancrediBiased agonism at serotonin 5-HT1A receptors: preferential postsynaptic activity for improved therapy of CNS disordersNeuropsychiatry2011114916410.2217/npy.11.12
– reference: Jastrzębska-WięsekMPartykaARychtykJŚniecikowskaJKołaczkowskiMWesołowskaAVarneyMANewman-TancrediAActivity of serotonin 5-HT1A receptor biased agonists in rat: anxiolytic and antidepressant-like propertiesACS Chem Neurosci201891040105010.1021/acschemneuro.7b00443
– reference: HandleySL5-hydroxytryptamine pathways in anxiety and its treatmentPharmacol Ther1995661031481:CAS:528:DyaK2MXoslCnt7k%3D10.1016/0163-7258(95)00004-Z
– reference: Aguilar A, Camacho J, Chino S, Jácquez P, López E (1994) Herbario de Medicina del Instituto Mexicano del Seguro Social. Información etnobotánica. México: Instituto Mexicano del Seguro Social pp. 159, 245.
– reference: CryanJFValentinoRJLuckiIAssessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming testNeurosci Biobehav Rev2005295475691:CAS:528:DC%2BD2MXltFWlurg%3D10.1016/j.neubiorev.2005.03.008
– reference: HedlundPBKellyLMazurCLovenbergTSutcliffeJGBonaventureP8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodentsEur J Pharmacol20044871251321:CAS:528:DC%2BD2cXitFeiu7s%3D10.1016/j.ejphar.2004.01.031
– reference: ListerRGThe use of a plus-maze to measure anxiety in the mousePsychopharmacology1987921801851:CAS:528:DyaL2sXktlejurc%3D3110839
– reference: PrutLBelzungCThe open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a reviewEur J Pharmacol20034633331:CAS:528:DC%2BD3sXhsVanu70%3D10.1016/S0014-2999(03)01272-X
– reference: DiazSMaroteauxLImplication of 5-HT(2B) receptors in the serotonin syndromeNeuropharmacol2011614955021:CAS:528:DC%2BC3MXntFWiu78%3D10.1016/j.neuropharm.2011.01.025
– reference: OkugawaHUedaRMatsumotoKKawanishiKKatoKEffects of sesquiterpenoids from “Oriental incenses” on acetic acid-induced writhing and D2 and 5-HT2A receptors in rat brainPhytomedicine200074174221:CAS:528:DC%2BD3cXoslWis7o%3D10.1016/S0944-7113(00)80063-X
– reference: OnaiviESBishop-RobinsonCDarmaniNASandres-BushEBehavioral effects of (+/)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, (DOI) in the elevated plus- maze testLife Sci199557245524661:CAS:528:DyaK2MXpsFemtr4%3D10.1016/0024-3205(95)02242-9
– reference: CritchleyMAHandleySLEffects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptorsPsychopharmacology1987935025061:CAS:528:DyaL1cXmvVOlsw%3D%3D10.1007/BF00207243
– reference: MoserPCTricklebankMDMiddlemissDNMirAKHibertMFFozardJRCharacterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepamBr J Pharmacol1990993433491:CAS:528:DyaK3cXhsFWlsrY%3D10.1111/j.1476-5381.1990.tb14706.x
– reference: CeladaPPuigMAmargós-BoschMAdellAArtigasFThe therapeutic role of 5-HT1A and 5-HT2A receptors in depressionJ Psychiatry Neurosci20042925226515309042446220
– reference: OkugawaHUedaRMatsumotoKKawanishiKKayoAEffect of Jnokoh- eremol and Agarospirol from Agarwood on the central nervous system in micePlanta Med1995622610.1055/s-2006-957784
– reference: RosaADeianaMAtzeriACoronaGIncaniAMelisMPAppendinoGDessìMAEvaluation of the antioxidant and cytotoxic activity of arzanol, a prenylated alpha-pyrone-phloroglucinol etherodimer from Helichrysum italicum subsp. microphyllumChem-Biol Interact20071651171261:CAS:528:DC%2BD2sXls1eiuw%3D%3D10.1016/j.cbi.2006.11.006
– reference: HeerleinAAntidepressant pharmacologic treatmentsRev Chil Neuro-Psiquiat2002403951
– reference: VarmaKRMaheshwariMLBhattacharyyaSCTerpenoids-LXII: The constitution of agarospirol, a sesquiterpenoid with a new skeletonTetrahedron1965211151381:CAS:528:DyaF2MXksVSksQ%3D%3D10.1016/S0040-4020(01)82208-0
– reference: CristJSurprenantAEvidence that 8-hydroxy-2-(n-dipropylamino) tetralin (8-OH-DPAT) is a selective α2-adrenoceptor antagonist on guinea-pig submucous neuronsBr J Pharmacol1987923413471:CAS:528:DyaL2sXlvFSqsb8%3D10.1111/j.1476-5381.1987.tb11329.x
– reference: MarkouACryanJFStress, anxiety and depression: toward new treatment strategiesNeuropharmacology201262121:CAS:528:DC%2BC3MXhtlaktL3E10.1016/j.neuropharm.2011.09.023
– reference: Villalobos-OsorioDRamírez-GonzálezIRojas-FermínLSantiago-SilvaBCarmona- ArzolaJAvedaño-MezaMComposición del aceite esencial y caracterización fisicoquímica de las hojas de Stachytarpheta mutabilis (Jacq.) VahlAv Quím201491519
– reference: FajemiroyeJOGaldinoPMFlorentinoIRDa RochaFFGhediniPCPolepallyPRZjawionyJKCostaEAPlurality of anxiety and depression alteration mechanism by oleanolic acidJ Psychopharmacol2014892393410.1177/0269881114536789
– reference: CeladaPBortolozziAArtigasFSerotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of researchCNS Drugs2013277037161:CAS:528:DC%2BC3sXhvVSmsbbN10.1007/s40263-013-0071-0
– reference: DSM-V. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596
– reference: MoraSMillánRLungenstrassHDíaz-VélizGMoránJAHerrera-RuizMTortorielloJThe hydroalcoholic extract of Salvia elegans induces anxiolytic- and antidepressant-like effects in ratsJ Ethnopharmacol200610676811:STN:280:DC%2BD283otl2lsA%3D%3D10.1016/j.jep.2005.12.004
– reference: MottaVMaisonnetteSMoratoSCastrechiniPBrandãoMLEffects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-mazePsychopharmacology19921071351391:CAS:528:DyaK38Xit1yrsLk%3D10.1007/BF02244978
– reference: Van HeeringenKMannJJThe Neurobiology of SuicideLancet Psychiatry20141637210.1016/S2215-0366(14)70220-2
– reference: World Health OrganizationReport: depression and other common metal disorders2017GenevaGlobal Health Estimates
– reference: González-CortazarMMaldonado-AbarcaAMJiménez-FerrerEMarquinaSVentura- ZapataEZamilpaATortorielloJHerrera-RuizMIsosakuranetina- 5-O- rutinoside: a new flavanone with antidepressant activity isolated from Salvia elegans VahlMolecules201318132601327010.3390/molecules181113260
– reference: Herrera-RuizMGarcíaYMoraSDíazGVianaSTortorielloJRamírezGAntidepressant and anxiolytic effects of hydroalcoholic extract from Salvia elegansJ Ethnopharmacol2006107535810.1016/j.jep.2006.02.003
– volume: 66
  start-page: 103
  year: 1995
  ident: 2155_CR12
  publication-title: Pharmacol Ther
  doi: 10.1016/0163-7258(95)00004-Z
– ident: 2155_CR1
– volume: 92
  start-page: 341
  year: 1987
  ident: 2155_CR4
  publication-title: Br J Pharmacol
  doi: 10.1111/j.1476-5381.1987.tb11329.x
– volume: 21
  start-page: 115
  year: 1965
  ident: 2155_CR31
  publication-title: Tetrahedron
  doi: 10.1016/S0040-4020(01)82208-0
– volume: 62
  start-page: 1
  year: 2012
  ident: 2155_CR19
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2011.09.023
– volume: 106
  start-page: 76
  year: 2006
  ident: 2155_CR20
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2005.12.004
– volume: 8
  start-page: 923
  year: 2014
  ident: 2155_CR10
  publication-title: J Psychopharmacol
  doi: 10.1177/0269881114536789
– volume: 9
  start-page: 1040
  year: 2018
  ident: 2155_CR17
  publication-title: ACS Chem Neurosci
  doi: 10.1021/acschemneuro.7b00443
– volume: 27
  start-page: 703
  year: 2013
  ident: 2155_CR3
  publication-title: CNS Drugs
  doi: 10.1007/s40263-013-0071-0
– volume: 57
  start-page: 2455
  year: 1995
  ident: 2155_CR26
  publication-title: Life Sci
  doi: 10.1016/0024-3205(95)02242-9
– volume: 87
  start-page: 129
  year: 2018
  ident: 2155_CR9
  publication-title: Psychother Psychosom
  doi: 10.1159/000488945
– volume: 107
  start-page: 135
  year: 1992
  ident: 2155_CR22
  publication-title: Psychopharmacology
  doi: 10.1007/BF02244978
– volume: 29
  start-page: 547
  year: 2005
  ident: 2155_CR6
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2005.03.008
– volume: 266
  start-page: 730
  year: 1977
  ident: 2155_CR27
  publication-title: Nature
  doi: 10.1038/266730a0
– volume: 1
  start-page: 63
  year: 2014
  ident: 2155_CR30
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(14)70220-2
– volume: 40
  start-page: 39
  year: 2002
  ident: 2155_CR14
  publication-title: Rev Chil Neuro-Psiquiat
– volume: 93
  start-page: 502
  year: 1987
  ident: 2155_CR5
  publication-title: Psychopharmacology
  doi: 10.1007/BF00207243
– volume: 463
  start-page: 3
  year: 2003
  ident: 2155_CR28
  publication-title: Eur J Pharmacol
  doi: 10.1016/S0014-2999(03)01272-X
– volume: 150
  start-page: 361
  year: 1988
  ident: 2155_CR16
  publication-title: Eur J Pharmacol
  doi: 10.1016/0014-2999(88)90019-2
– ident: 2155_CR8
  doi: 10.1176/appi.books.9780890425596
– volume: 92
  start-page: 180
  year: 1987
  ident: 2155_CR18
  publication-title: Psychopharmacology
– volume: 99
  start-page: 343
  year: 1990
  ident: 2155_CR21
  publication-title: Br J Pharmacol
  doi: 10.1111/j.1476-5381.1990.tb14706.x
– volume: 165
  start-page: 117
  year: 2007
  ident: 2155_CR29
  publication-title: Chem-Biol Interact
  doi: 10.1016/j.cbi.2006.11.006
– volume: 61
  start-page: 495
  year: 2011
  ident: 2155_CR7
  publication-title: Neuropharmacol
  doi: 10.1016/j.neuropharm.2011.01.025
– volume: 107
  start-page: 53
  year: 2006
  ident: 2155_CR15
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2006.02.003
– volume: 9
  start-page: 15
  year: 2014
  ident: 2155_CR32
  publication-title: Av Quím
– volume: 62
  start-page: 2
  year: 1995
  ident: 2155_CR24
  publication-title: Planta Med
  doi: 10.1055/s-2006-957784
– volume: 18
  start-page: 13260
  year: 2013
  ident: 2155_CR11
  publication-title: Molecules
  doi: 10.3390/molecules181113260
– volume-title: Report: depression and other common metal disorders
  year: 2017
  ident: 2155_CR33
– volume: 487
  start-page: 125
  year: 2004
  ident: 2155_CR13
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2004.01.031
– volume: 1
  start-page: 149
  year: 2011
  ident: 2155_CR23
  publication-title: Neuropsychiatry
  doi: 10.2217/npy.11.12
– volume: 29
  start-page: 252
  year: 2004
  ident: 2155_CR2
  publication-title: J Psychiatry Neurosci
– volume: 7
  start-page: 417
  year: 2000
  ident: 2155_CR25
  publication-title: Phytomedicine
  doi: 10.1016/S0944-7113(00)80063-X
SSID ssj0006155
Score 2.3505752
Snippet Salvia elegans belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and...
Salvia elegans belongs to a genus plants with biological activities in central nervous system. In this work, the purpose was to evaluate the anxiolytic and...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2419
SubjectTerms Agonists
Animals
Anti-Anxiety Agents - administration & dosage
Anti-Anxiety Agents - isolation & purification
Anti-Anxiety Agents - pharmacology
Antidepressants
Antidepressive Agents - administration & dosage
Antidepressive Agents - isolation & purification
Antidepressive Agents - pharmacology
Behavior, Animal - drug effects
Biomedical and Life Sciences
Biomedicine
Central nervous system
Column chromatography
Disease Models, Animal
Dose-Response Relationship, Drug
Drug interaction
Drug Interactions
Drugs
Male
Maze Learning - drug effects
Mice
Mice, Inbred ICR
Neurosciences
Oleanolic acid
Open-field behavior
Original Article
Pharmacology/Toxicology
Plant Extracts - administration & dosage
Plant Extracts - pharmacology
Salvia - chemistry
Salvia elegans
Serotonin
Serotonin Agents - administration & dosage
Serotonin Agents - pharmacology
Serotonin S1 receptors
Serotonin S2 receptors
Swimming
Terpenes
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS8MwEA86X3wRv61OiSB7cYW0adr0cYhjCMrADfZWkjaVwthk3cT99971a8hU8KF9SdKU3DX3S-_ud4TcGcljDdDWNhzdjG7KbOmHic012GbO05Br_DXw_OIPxt7TREyqpLC8jnavXZLFTt0kuxXHExtDCtBOCdvfJXsC-aRAi8dur9l_0dNWcy-DNZNVqszPz_hujrYw5pZ_tDA7_UNyUOFF2isFfER2zOyYdIYl4fS6S0eb_Km8Szt0uKGiXp8QrIOQVcGusIRUzRK4PrP5dA0DKMaTY1mlnGaggoA6E4rpJvRVTT8yRbEkBVgyipQSmExF8actBZ2dI4P3AvZMmixWb_kpGfcfRw8DuyqsYMc8EEvb1bHgsQuHaqMAghkW6DRMjIf0ZlL7QQpG2w8YtAax9k3oQ1cj0oAp7mgBmOOMtGYw0QWhTDtJrFjKEm280JFSx6EjVMATJxWKuRZx6vWN4op1HItfTKOGL7mQSQS3qJBJ5FvkvhnzXnJu_Nm7XYstqr6_PIJDXQBAxZPwArdNM3w56A5RMzNfFX2QiRkwjkXOS3E303HAlRKgsUW6tfw3D__9XS7_1_2K7Luoi0V0TJu0louVuQaMs9Q3hUp_AY9q8g8
  priority: 102
  providerName: Springer Nature
Title Antidepressant and anxiolytic compounds isolated from Salvia elegans interact with serotonergic drugs
URI https://link.springer.com/article/10.1007/s00210-021-02155-6
https://www.ncbi.nlm.nih.gov/pubmed/34568977
https://www.proquest.com/docview/2597613482
https://www.proquest.com/docview/2598075218
Volume 394
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED-69mUvY1v34a0tKoy-LGK2FfnjaaQjbWlZCVsD2ZPRl0cgJF2cjOW_350iO4yyPtgGW7aE7qz7Sbr7HcAHVwijEdpyJ2ibMa1jXmSl5UKjbRaiLoWmpYGvt9nVuH89kZOw4NYEt8p2TPQDtV0YWiP_hDAdZ9xExfL5_henrFG0uxpSaDyBgwSRCKVuyCfdhIustWxZmNGuFSFoxofO-ckOJwcFsnqSZ_8apgdo88FOqTdAF8_hWUCObLAV9QvYc_OXcDbaUk9veuxuF0nV9NgZG-1IqTeHQBkRpsHtFTuTqbnF4890MdvgC4w8yynBUsOmqIyIPy2jwBP2Xc1-TxWj5BRo0xiRS1BYFaPlW4bauyAu7yWOnswu1z-bVzC-GN59ueIhxQI3IpcrnmojhUlxeu0UgjEX57ouresT0Vmhs7xG853lMT7Njc5cmWFRJ-s8ViLREtHHa9ifY0VvgcU6sUbFdWy165dJUWhTJlLlwia1VHEaQdL2b2UC_zilwZhVHXOyl0mFp8rLpMoi-Ni9c79l33i09FErtir8iU2105sITrvH-A_Rxoiau8XalyFOZkQ7EbzZirurTiDCLBAkR9Br5b_7-P_b8u7xtryHpynpnveLOYL91XLtjhHdrPSJV-ETOBhc_rgZ4vV8eDv6hnfH6eAvwAj5Xg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6V9AAXxBvTAosEvZAVtjd-HSrEo1VK2yiCVOrN7MsoUpS0cQLkz_HbmNmsHaGK3nqwL14_5Nnd79udmW8AXttcaIXUlltBbsa4CnmeFoYLhdgsRFUIRVsDp4O0f9b7cp6cb8GfJheGwiqbOdFN1GamaY_8HdJ0XHGTFMv7i0tOVaPIu9qU0JC-tILZdxJjPrHj2K5-4RKu3j_6jPZ-E8eHB6NPfe6rDHAtsmTBY6UToWNcYVqJfMSGmaoKY3uk9ZWrNKsQwdIsxKuZVqktUmxqkyoLpYhUggCMz70F2z3aQOnA9seDwfBriwXk9Wt0oBFZc5-245L33HKLU4gE4W7C03-h8QrfveKrdRB4eA_ueu7KPqw7233YstMHsDdci1-vumy0yeWqu2yPDTey2KuHQDUZxj7wFs3J5NTg8Xs8m6zwBkax7VTiqWZjHA7IgA2j1Bf2TU5-jiWj8hiIqozkLSixi9EGMsPxMyM18TnO38zMlz_qR3B2I7__MXSm-KKnwEIVGS3DKjTK9oooz5UuokRmwkRVIsM4gKj5v6X2CuhUiGNSttrNziYlnkpnkzIN4G17z8Va_-Pa1ruN2Uo_F9TlpucG8Kq9jKOYXDNyamdL14ZUoZFvBfBkbe72dQI5bo40PYBuY__Nw___Lc-u_5aXcLs_Oj0pT44GxztwJ6Z-6KJ0dqGzmC_tc-RaC_XCd2gG3296DP0FOKw5Ag
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVkJcKsrTpYVFgl7IqrY3fh0qBLRRSyGKoJV6M_tyFSlK2jgB8hf5Vcxs1o5QRW892BevH_Ls7HyzM_MNwBubC60Q2nIrKMwYVyHP08JwodA2C1EVQtHWwNd-enze_XyRXKzBn6YWhtIqmzXRLdRmommPfB9hOnrcRMWyX_m0iMFh7_3VNacOUhRpbdppSN9mwRw4ujFf5HFqF7_QnasPTg5R9m_juHd09umY-44DXIssmfFY6UToGL1NKxGb2DBTVWFsl3i_cpVmFVqzNAvxaqZVaosUh9qkykIpIpWgMcbn3oONDK0-OoIbH4_6g2-tXaAIYMMJjVY29yU8rpDPuV6c0iXIBic8_ddM3sC-N-K2zhz2HsKmx7Hsw3LibcGaHT-CvcGSCHvRYWeruq66w_bYYEWRvXgM1J9h6JNwUbRMjg0ev4eT0QJvYJTnTu2eajZE1UA0bBiVwbDvcvRzKBm1ykALy4jqgoq8GG0mM9SlCTGLT3EtZ2Y6v6yfwPmd_P6nsD7GFz0HFqrIaBlWoVG2W0R5rnQRJTITJqoSGcYBRM3_LbVnQ6emHKOy5XF2MinxVDqZlGkA79p7rpZcILeO3mnEVvp1oS5XsziA1-1l1GgK08ixnczdGGKIRuwVwLOluNvXCcS7OUL2ADqN_FcP__-3bN_-La_gPupS-eWkf_oCHsQ0DV3Czg6sz6Zzu4uwa6Ze-vnM4Mddq9BfDFk9Rg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antidepressant+and+anxiolytic+compounds+isolated+from+Salvia+elegans+interact+with+serotonergic+drugs&rft.jtitle=Naunyn-Schmiedeberg%27s+archives+of+pharmacology&rft.au=Mart%C3%ADnez-Hern%C3%A1ndez%2C+Gabriela+Belen&rft.au=Jim%C3%A9nez-Ferrer%2C+Enrique&rft.au=Gonz%C3%A1lez-Cortazar%2C+Manases&rft.au=Rom%C3%A1n-Ramos%2C+Rub%C3%A9n&rft.date=2021-12-01&rft.eissn=1432-1912&rft.volume=394&rft.issue=12&rft.spage=2419&rft_id=info:doi/10.1007%2Fs00210-021-02155-6&rft_id=info%3Apmid%2F34568977&rft.externalDocID=34568977
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-1298&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-1298&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-1298&client=summon